Astrazeneca Pharma India Hits 52-Week High, Outperforms Sector by 12.43%

Astrazeneca Pharma India, a leading pharmaceutical company in India, has recently hit a 52-week high on September 30, 2024. The stock has been performing well, outperforming the sector by 12.43% on the same day. The stock has also shown a trend reversal, gaining after three consecutive days of fall.

On September 30, the stock touched an intraday high of Rs. 8139.85, which is a 13.28% increase from the previous day's closing price. The stock has also shown high volatility, with an intraday volatility of 5.63%, calculated from the weighted average price.

Astrazeneca Pharma India is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the stock's performance.

In the past year, Astrazeneca Pharma India has shown a remarkable growth of 77.23%, while the Sensex has only grown by 28.04%. This showcases the company's strong performance and potential for future growth.

MarketsMOJO has given a 'Hold' call for Astrazeneca Pharma India, indicating that the stock is expected to perform steadily in the near future. With its strong performance and positive outlook, Astrazeneca Pharma India continues to be a top player in the pharmaceutical industry in India.